Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.13+0.57 (+6.66%)
Close on Nov 19, 2026Market cap $815.28MP/E –Yield –
Syndax Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Syndax Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2018 was -$68.72M. For fiscal 2025 it was -$323.17M. The highest annual figure on record is $29.00M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$323.17M | – |
| FY2024 | Dec 31, 2024 | -$274.90M | – |
| FY2023 | Dec 31, 2023 | -$160.60M | – |
| FY2022 | Dec 31, 2022 | -$133.68M | -560.9% |
| FY2021 | Dec 31, 2021 | $29.00M | – |
| FY2020 | Dec 31, 2020 | -$71.26M | – |
| FY2018 | Dec 31, 2018 | -$68.72M | – |
| FY2017 | Dec 31, 2017 | -$47.46M | – |
| FY2016 | Dec 31, 2016 | -$35.42M | – |
| FY2015 | Dec 31, 2015 | -$2.48M | – |
| FY2014 | Dec 31, 2014 | -$14.40M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | -$15.06M | – |
| Q3 FY2018 | Sep 30, 2018 | -$18.47M | – |
| Q2 FY2018 | Jun 30, 2018 | -$15.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$20.04M | – |
| Q4 FY2017 | Dec 31, 2017 | -$12.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.42M | – |
See a number that looks wrong?